Anemia Associated with Chronic Kidney Disease

• CLINICAL_TRIALS withdrawal · 2022-07-05
  Clinical Trial Update: Investigating the Efficacy, Safety and PK of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKD [Phase 3]

  A Phase 3 clinical trial investigating Roxadustat (FG-4592) for anemia in pediatric CKD has been withdrawn.

• CLINICAL_TRIALS trial_result · 2021-08-09
  Clinical Trial Update: Investigating the Efficacy and Safety of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKD [Phase 3]

  A Phase 3 clinical trial update investigates the efficacy and safety of Roxadustat for treating anemia in pediatric patients with chronic ki…

• CLINICAL_TRIALS trial_result · 2017-11-09
  Clinical Trial Update: 4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis [Phase 2]

  Phase 2 trial evaluating a 4-week correction regimen for anemia in adults with chronic kidney disease not on dialysis; the study is complete…

• FDA label_change · 2006-05-11
  FDA Approved: PROCRIT — Supplemental Application (Janssen Products, LP)

  FDA approved a supplemental application for PROCRIT (epoetin alfa) from Janssen, resulting in labeling changes.